Nephro Care India Share Price
Start SIP in Nephro Care India
Start SIPNephro Care India Performance
Day Range
- Low 262
- High 266
52 Week Range
- Low 171
- High 379
- Open Price262
- Previous Close262
- Volume16000
Nephro Care India Investment Rating
-
Master Rating:
-
Nephro Care India Ltd has an operating revenue of Rs. 49.57 Cr. on a trailing 12-month basis. An annual revenue growth of 61% is outstanding, Pre-tax margin of 23% is great, ROE of 29% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 72 which is FAIR indicating the recent price performance, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 108 indicates it belongs to a poor industry group of Medical-Hospitals and a Master Score of D is close to being the worst. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Mar 2024 | Mar 2023 |
|---|---|---|
| Total Revenue Annual Cr | 28 | 17 |
| Operating Expenses Annual Cr | 21 | 13 |
| Operating Profit Annual in Cr | 6 | 4 |
| Depreciation Cr | 1 | 1 |
| Interest Annual Cr | 0 | 0 |
| Tax Annual Cr | 2 | 1 |
| Net Profit Annual Cr | 4 | 2 |
Nephro Care India Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 5
- Bearish Moving Average
- ___
- 6
- 20 Day
- ₹266.77
- 50 Day
- ₹269.52
- 100 Day
- ₹
- 200 Day
- ₹
- 20 Day
- ₹271.11
- 50 Day
- ₹271.39
- 100 Day
- ₹
- 200 Day
- ₹
Nephro Care India Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 267.30 |
| Second Resistance | 268.65 |
| Third Resistance | 271.30 |
| RSI | 50.47 |
| MFI | 14.32 |
| MACD Single Line | -0.12 |
| MACD | -2.86 |
| Support | |
|---|---|
| First Support | 263.30 |
| Second Support | 260.65 |
| Third Supoort | 259.30 |
Nephro Care India Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 16,000 | 1,280,000 | 80 |
| Week | 26,560 | 2,112,051 | 79.52 |
| 1 Month | 72,218 | 4,800,343 | 66.47 |
| 6 Month | 109,776 | 6,858,780 | 62.48 |
Nephro Care India Result Highlights
Nephro Care India Synopsis
NSE-Medical-Hospitals
Nephro Care India belongs to the Industry of Hospitals & Medical Services. Company’s Total Operating Revenue is Rs. 27.23 Cr. and Equity Capital is Rs. 11.90 Cr. for the Year ended 31/03/2024. Nephro Care India Ltd. is a Public Limited Listed company incorporated on 08/07/2014 and has its registered office in the State of West Bengal, India. Company’s Corporate Identification Number(CIN) is U85100WB2014PLC202429 and registration number is 202429.| Market Cap | 433 |
| Sales | 27 |
| Shares in Float | 0.64 |
| No of funds | |
| Yield |
| Book Value | 20.79 |
| U/D Vol ratio | 0.9 |
| LTDebt / Equity | 99 |
| Alpha | 0.75 |
| Beta | 1.69 |
Nephro Care India Shareholding Pattern
| Owner Name |
|---|
Nephro Care India Management
| Name | Designation |
|---|---|
| Dr. Pratim Sengupta | Managing Director |
| Dr. Pritam Sengupta | Director |
| Dr. Sutapa Sen | Director |
| Mr. Saikat Biswas | Independent Director |
| Mr. Sudip Barman | Independent Director |
| Mr. Alo Sengupta | Independent Director |
| Mr. Sandeep Shridhar Ghate | Addnl. & Non Exe.Director |
| Mr. Debashish Ghoshal | Addnl. & Non Exe.Director |
Nephro Care India Forecast
Price Estimates
Nephro Care India Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-08-20 | Audited Results | To consider and approve the financial results for the period ended March 31, 2024 and other business matters |
| 2024-07-19 | Others | To consider other business matters |
Nephro Care India FAQs
What is Share Price of Nephro Care India ?
Nephro Care India share price is ₹265 As on 18 September, 2024 | 02:25
What is the Market Cap of Nephro Care India ?
The Market Cap of Nephro Care India is ₹438.5 Cr As on 18 September, 2024 | 02:25
What is the P/E ratio of Nephro Care India ?
The P/E ratio of Nephro Care India is As on 18 September, 2024 | 02:25
What is the PB ratio of Nephro Care India ?
The PB ratio of Nephro Care India is 29.2 As on 18 September, 2024 | 02:25